A LC–MS/MS method for therapeutic drug monitoring of sorafenib, regorafenib and their active metabolites in patients with hepatocellular carcinoma
- Resource Type
- Article
- Source
- In
Journal of Pharmaceutical and Biomedical Analysis 5 August 2020 187 - Subject
- Language
- ISSN
- 0731-7085